Cytokinetics, Inc. (CYTK) Posts Q2 Loss of 23c/Share
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $80.01 --0%
EPS Growth %: -46.4%
Financial Fact:
Interest and other, net: 111K
Today's EPS Names:
CRWS, MEI, PODC, More
EPS Growth %: -46.4%
Financial Fact:
Interest and other, net: 111K
Today's EPS Names:
CRWS, MEI, PODC, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q2 EPS of ($0.23), $0.09 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $7.8 million versus the consensus estimate of $7.01 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Alimentation Couche-Tard Inc (ATD/B:CN) (ANCUF) PT Raised to Cdn$104 at UBS
- Green Dot and CommerceOne shareholders approve acquisition deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
